Blog

AXIS INDIA MANUFACTURING FUND

Here is a new gift for our customers from Axis Mutual Fund. Axis Mutual fund had just launched a new manufacturing fund, which is probably going to be very much attractive for many. The scheme is ‘Axis India Manufacturing Fund’. This is an open-ended equity scheme, which is a benchmark upon NIFTY India Manufacturing TRI. The scheme is opened on 1st December 2023 and will be available till 15th December 2023. The main aim of this investment-scheme is to provide long-term capital appreciation by investing in certain institutions, involved in manufacturing themes like capital goods, consumer durables, textiles, pharmaceuticals etc.

This fund is going to follow a bottom-up approach with a multi-cap stock selection strategy. In addition to adoption of an active sectoral allocation and a proper style of investments, the ‘Axis India Manufacturing Fund’ is going to focus on the under-represented segments of Indian listed markets. The products will be suitable for investors who are seeking – i) Capital appreciation over long-term and ii) An equity-scheme investing in Indian equity and equity related securities of companies engaged in manufacturing themes. 

The fund is aiming to identify companies across three segments of Indian Economy ; 

1) Investments (Capex cycle) : Manufacturers investing in factory equipments and to grow production capacity.

2) Consumption (Increasing income leading to premiumzation) : Industries with rising demand trajectory due to domestic consumption and premiumization narrative.

3) Net Exports (Focus on import substitution) :  Focus on companies benefitting from India’s integration into the global supply chain.

Axis India Manufacturing Fund is overall identified as a conduit for investors to leverage the promising opportunities that exist within India’s manufacturing themes. As usual, the investments in Mutual funds are subjected to market-risks – so one should go through all the scheme related documents carefully before investments. Also the investors must consult their financial advisors if in doubt about whether the products will be suitable for them.